Cargando…
Factor H Autoantibodies and Complement-Mediated Diseases
Factor H (FH), a member of the regulators-of-complement-activation (RCA) family of proteins, circulates in human plasma at concentrations of 180–420 mg/L where it controls the alternative pathway (AP) of complement in the fluid phase and on cell surfaces. When the regulatory function of FH is impair...
Autores principales: | Zhang, Yuzhou, Ghiringhelli Borsa, Nicolo, Shao, Dingwu, Dopler, Arthur, Jones, Michael B., Meyer, Nicole C., Pitcher, Gabriella R., Taylor, Amanda O., Nester, Carla M., Schmidt, Christoph Q., Smith, Richard J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770156/ https://www.ncbi.nlm.nih.gov/pubmed/33384694 http://dx.doi.org/10.3389/fimmu.2020.607211 |
Ejemplares similares
-
Complement Factor I Variants in Complement-Mediated Renal Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2022) -
Factor B and C4b2a Autoantibodies in C3 Glomerulopathy
por: Hauer, Jill J., et al.
Publicado: (2019) -
Tuning the Functionality by Splicing: Factor H and Its Alternative Splice Variant FHL-1 Share a Gene but Not All Functions
por: Mannes, Marco, et al.
Publicado: (2020) -
Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels
por: Golomingi, Murielle, et al.
Publicado: (2023) -
Autoantibodies against complement factor B in rheumatoid arthritis
por: Matola, Alexandra T., et al.
Publicado: (2023)